GSK Plc (GLAXF)

25.70 +0.23 (+0.91%) USD  |  OTCM  |  May 13, 16:00
More

GSK EPS Diluted (Quarterly) : 0.5745 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for GLAXF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 0.9849
Hikma Pharmaceuticals Plc --
Allergy Therapeutics Plc --
Shield Therapeutics Plc --

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) 2.478B
Revenue (Quarterly) 10.28B
Total Expenses (Quarterly) 7.939B
Enterprise Value 123.19B
Gross Profit Margin (Quarterly) 75.45%
Profit Margin (Quarterly) 24.11%
Earnings Yield 7.44%
Operating Earnings Yield 9.45%
Normalized Earnings Yield 8.120